About Choline kinase alpha
Choline kinase alpha (CHKA) is a protein
from Homo sapiens identified by UniProt accession
P35790, 457 residues long.
MolForge cross-references it against 0 known binders and
238 disease associations.
Target properties
| Protein name | Choline kinase alpha |
| UniProt accession | P35790 |
| Gene | CHKA |
| Organism | Homo sapiens |
| Length | 457 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (238)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures · score 0.65
- Microcephaly · score 0.60
- Seizure · score 0.60
- Global developmental delay · score 0.50
- Intellectual disability · score 0.50
- Abnormal muscle tone · score 0.50
- Abnormality of movement · score 0.50
- microcephaly · score 0.50
- Short stature · score 0.50
- neurodegenerative disease · score 0.41
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P35790-F1 | alphafold | PREDICTED | 82.32 | — |
Amino-acid sequence (457 residues)
MKTKFCTGGE AEPSPLGLLL SCGSGSAAPA PGVGQQRDAA SDLESKQLGG QQPPLALPPP PPLPLPLPLP QPPPPQPPAD EQPEPRTRRR AYLWCKEFLP GAWRGLREDE FHISVIRGGL SNMLFQCSLP DTTATLGDEP RKVLLRLYGA ILQMRSCNKE GSEQAQKENE FQGAEAMVLE SVMFAILAER SLGPKLYGIF PQGRLEQFIP SRRLDTEELS LPDISAEIAE KMATFHGMKM PFNKEPKWLF GTMEKYLKEV LRIKFTEESR IKKLHKLLSY NLPLELENLR SLLESTPSPV VFCHNDCQEG NILLLEGREN SEKQKLMLID FEYSSYNYRG FDIGNHFCEW MYDYSYEKYP FFRANIRKYP TKKQQLHFIS SYLPAFQNDF ENLSTEEKSI IKEEMLLEVN RFALASHFLW GLWSIVQAKI SSIEFGYMDY AQARFDAYFH QKRKLGV
Explore Choline kinase alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets